Jennifer Walker-Daniels, Ph.D.
Affiliations: | 2001 | Purdue University, West Lafayette, IN, United States |
Area:
Cell Biology, OncologyGoogle:
"Jennifer Walker-Daniels"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael S. Kinch | grad student | 2001 | Purdue | |
| (The regulation of elevated EphA2 protein levels in metastatic cancer cells: Roles for ligand binding, protein degradation, and c -Cbl.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Walker-Daniels J, Hess AR, Hendrix MJ, et al. (2003) Differential regulation of EphA2 in normal and malignant cells. The American Journal of Pathology. 162: 1037-42 |
| Walker-Daniels J, Riese DJ, Kinch MS. (2002) c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Molecular Cancer Research : McR. 1: 79-87 |
| Zelinski DP, Zantek ND, Walker-Daniels J, et al. (2002) Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase. Journal of Cellular Biochemistry. 85: 714-20 |
| Dodge Zantek N, Walker-Daniels J, Stewart J, et al. (2001) MCF-10A-NeoST: A new cell system for studying cell-ECM and cell-cell interactions in breast cancer Clinical Cancer Research. 7: 3640-3648 |
| Fenrick R, Wang L, Nip J, et al. (2000) TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Molecular and Cellular Biology. 20: 5828-39 |
| Walker-Daniels J, Coffman K, Azimi M, et al. (1999) Overexpression of the EphA2 tyrosine kinase in prostate cancer. The Prostate. 41: 275-80 |